Arthur Berken

572 total citations · 1 hit paper
10 papers, 459 citations indexed

About

Arthur Berken is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arthur Berken has authored 10 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arthur Berken's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Barrier Structure and Function Studies (1 paper). Arthur Berken is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Barrier Structure and Function Studies (1 paper). Arthur Berken collaborates with scholars based in United States. Arthur Berken's co-authors include Baruj Benacerraf, M. Wolman and David I. Rosenthal and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Arthur Berken

10 papers receiving 346 citations

Hit Papers

PROPERTIES OF ANTIBODIES CYTOPHILIC FOR MACROPHAGES 1966 2026 1986 2006 1966 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur Berken United States 6 225 159 146 69 50 10 459
Pauline Byrt Australia 5 384 1.7× 169 1.1× 144 1.0× 53 0.8× 42 0.8× 7 601
Arnold Vogt Germany 16 133 0.6× 199 1.3× 84 0.6× 54 0.8× 77 1.5× 32 573
Susanne Bergstedt‐Lindqvist Sweden 7 423 1.9× 95 0.6× 125 0.9× 73 1.1× 39 0.8× 8 578
Sharwan K. Singhal Canada 18 674 3.0× 196 1.2× 145 1.0× 53 0.8× 47 0.9× 44 887
M Kingzette United States 10 247 1.1× 141 0.9× 114 0.8× 35 0.5× 55 1.1× 14 412
Geneviève Herman France 9 348 1.5× 230 1.4× 61 0.4× 51 0.7× 57 1.1× 10 573
O.B. Zaalberg Netherlands 9 267 1.2× 125 0.8× 99 0.7× 34 0.5× 54 1.1× 21 480
Stanley Cohen United States 12 214 1.0× 72 0.5× 58 0.4× 47 0.7× 25 0.5× 29 403
D R Stanworth United Kingdom 15 234 1.0× 158 1.0× 163 1.1× 136 2.0× 63 1.3× 28 656
T S Lieu United States 10 227 1.0× 179 1.1× 164 1.1× 16 0.2× 41 0.8× 12 515

Countries citing papers authored by Arthur Berken

Since Specialization
Citations

This map shows the geographic impact of Arthur Berken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Berken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Berken more than expected).

Fields of papers citing papers by Arthur Berken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Berken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Berken. The network helps show where Arthur Berken may publish in the future.

Co-authorship network of co-authors of Arthur Berken

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Berken. A scholar is included among the top collaborators of Arthur Berken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Berken. Arthur Berken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Berken, Arthur, et al.. (1982). High-frequency low-dose multiple-drug chemotherapy in advanced metastatic breast cancer. Cancer. 49(11). 2231–2233. 1 indexed citations
2.
Berken, Arthur. (1982). CASE FOR ADOPTIVE IMMUNOTHERAPY IN CANCER. The Lancet. 320(8309). 1190–1192. 1 indexed citations
3.
Berken, Arthur. (1981). Allopurinol-induced suppressor T cell dysfunction: A hypothesis. Journal of the American Academy of Dermatology. 5(5). 607–608. 7 indexed citations
4.
Berken, Arthur, et al.. (1974). Reticuloendothelial System Phagocytosis in Diabetes Mellitus. Diabetes. 23(3). 218–220. 6 indexed citations
5.
Berken, Arthur, et al.. (1972). Reticuloendothelial System Depression in Man After Olive Oil Ingestion. Experimental Biology and Medicine. 141(2). 656–658. 5 indexed citations
6.
Berken, Arthur & Baruj Benacerraf. (1968). Depression of Reticuloendothelial System Phagocytic Function by Ingested Lipids. Experimental Biology and Medicine. 128(3). 793–795. 18 indexed citations
7.
Berken, Arthur & Baruj Benacerraf. (1968). Sedimentation Properties of Antibody Cytophilic for Macrophages. The Journal of Immunology. 100(6). 1219–1222. 26 indexed citations
8.
Berken, Arthur & Baruj Benacerraf. (1966). PROPERTIES OF ANTIBODIES CYTOPHILIC FOR MACROPHAGES. The Journal of Experimental Medicine. 123(1). 119–144. 390 indexed citations breakdown →
9.
Berken, Arthur & M. Wolman. (1962). On the Nature of the Precipitate in the Generalized Shwartzman Reaction. The Journal of Immunology. 89(4). 490–495. 1 indexed citations
10.
Berken, Arthur. (1962). Ocular Changes in the Shwartzman Reaction. Archives of Ophthalmology. 67(4). 505–505. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026